MorphoSys and Vivoryon Therapeutics Enter Agreement on Small Molecule Inhibitors of CD47-SIRP alpha Signaling in Immuno-Oncology
PLANEGG, MUNICH and HALLE (SAALE), GERMANY / ACCESSWIRE / July 8, 2019 / MorphoSys AG (FSE: MOR; Prime Standard Segment;...